Introduction {#section1-2333794X19865440}
============

Cervical lymphadenopathy is a common complaint in the pediatric population. The prevalence rate of cervical lymphadenopathy, commonly defined as cervical nodal tissue measuring \>1 cm in diameter, is estimated at 38% to 45% in otherwise healthy children.^[@bibr1-2333794X19865440]^ The differential diagnosis for cervical lymphadenopathy in children is broad, including both common benign etiologies and much more rare malignant causes.^[@bibr1-2333794X19865440],[@bibr2-2333794X19865440]^ While myriad clinical trials, observational studies, and case series appear in the literature, a systematic review delineating the etiologies of pediatric cervical lymphadenopathy does not presently exist. The objectives of this study were to (1) identify the most common etiologies associated with pediatric cervical lymphadenopathy and (2) determine the relative prevalence of etiologies across a wide spectrum of patients.

Methods {#section2-2333794X19865440}
=======

Protocol {#section3-2333794X19865440}
--------

This study followed the guidelines of the Preferred Reporting Items in Systematic Reviews and Meta-Analyses.^[@bibr3-2333794X19865440]^

Eligibility {#section4-2333794X19865440}
-----------

In order to be included in this review, the following criteria were developed a priori: (1) any clinical trial, observational study, or cross-sectional case series with 10 or more subjects that included delineation of etiologies and/or associated conditions with lymphadenopathy; (2) ages 0 to 21 years with enlarged lymphoid tissue and lymphadenopathy confirmed by clinical evaluation; and (3) no specific diagnoses were excluded. Case reports, review articles, and editorials were excluded. There were no restrictions regarding date of publication or language; however, abstracts were required to be in English.

Information Sources {#section5-2333794X19865440}
-------------------

EMBASE, PubMed, and SCOPUS were searched electronically. Bibliographies of selected studies were reviewed manually as well.

Search {#section6-2333794X19865440}
------

The main search terms were "pediatric," "lymphadenopathy," and "children." The following filters were used during the search: human, no language restriction, no publication status restriction, all dates, ages 0 to 24 years. The search was performed individually by authors AD and KD. The results of the searches were pooled and duplicates were eliminated.

Study Selection {#section7-2333794X19865440}
---------------

Each article was evaluated by authors AD and KD. Any differences in judgment were resolved by consensus. All selected studies were reviewed by a third author MD.

Data Collection {#section8-2333794X19865440}
---------------

For each selected article, the following information was recorded: year and location of study population, definition of lymphadenopathy, percentage of lymphadenopathy that was cervical, total number of subjects, gender distribution of subjects, age range of patients, and specific etiologies. Major categories for specific etiologies for pediatric cervical lymphadenopathy included malignancy, nonspecific changes, and granulomatous, infectious, and autoimmune diseases. Within each of these categories more specific etiologies were developed from the data. Data extraction was performed by authors AD and KD and reviewed by MD.

Synthesis of Results {#section9-2333794X19865440}
--------------------

A Bayesian methodology for point estimation was used as previously described.^[@bibr4-2333794X19865440]^ Posterior probabilities are reported as rates with the associated 95% credible intervals. All calculations were performed in the R environment.

Sources of Bias Across Studies {#section10-2333794X19865440}
------------------------------

Potential sources of bias in this study include the following: inconsistency in individual studies regarding data in the text when compared with data presented in tables, inconsistencies in definition and terms across studies, and a percentage of patients with lymphadenopathy in areas other than cervical. To identify articles in which cervical lymphadenopathy was studied in conjunction with other regional lymphadenopathies, a broad search term of "lymphadenopathy" was used in the initial search terms. Once the source literature was pooled, eliminations were made to narrow the focus to cervical lymphadenopathy. Articles describing patients with peripheral lymphadenopathy in addition to cervical were accepted only if ≥90% of the subjects had cervical lymphadenopathy.

Ethical Approval and Informed Consent {#section11-2333794X19865440}
-------------------------------------

This study did not involve any direct contact with patients. Public data sources were solely used thus not requiring the institutional review board approval or patient consent.

Results {#section12-2333794X19865440}
=======

Study Selection {#section13-2333794X19865440}
---------------

The results of the literature search are summarized in [Figure 1](#fig1-2333794X19865440){ref-type="fig"}. Searches of EMBASE, PubMed, and SCOPUS resulted in 1790 articles. Reviews of the bibliographies of selected articles and a search of the OVID Cochrane Reviews failed to yield any additional source references. A total of 1750 studies were excluded after review of the title. An additional 21 were excluded after review of the abstract. The full texts of the remaining 19 articles were assessed in detail; 12 were excluded. Three of the discarded studies were review articles and 5 had exclusion and inclusion criteria that eliminated certain etiologies of cervical lymphadenopathy from the study. Another study was excluded because it did not specify the age range of the patients. Attempts to contact the author were not successful. Three articles were excluded because the percentage of children with cervical lymphadenopathy was less than 90%. Attempts to contact these authors were also not successful. The remaining 7 articles were selected for review. Though the final articles selected for review were only 7 of the original 1790, this was after carefully eliminating articles that failed to meet inclusion and exclusion criteria, and had sufficient data to draw conclusions specifically about pediatric cervical lymphadenopathy. Though a prevalent presenting symptoms in pediatric patients globally, and articles were reviewed from countries across the world including the United States, only these 7 met our criteria.

![Flow diagram of literature search.](10.1177_2333794X19865440-fig1){#fig1-2333794X19865440}

Study Characteristics and Outcomes {#section14-2333794X19865440}
----------------------------------

The 7 studies selected for this review are summarized in [Table 1](#table1-2333794X19865440){ref-type="table"}.^[@bibr5-2333794X19865440][@bibr6-2333794X19865440][@bibr7-2333794X19865440][@bibr8-2333794X19865440][@bibr9-2333794X19865440][@bibr10-2333794X19865440]-[@bibr11-2333794X19865440]^ These studies ranged in size from 49 to 1700 subjects and had a combined total of 2687 children. The subjects represent a global pediatric population from Nigeria, Turkey, Italy, India, and Egypt.

###### 

Summary of Included Studies.

![](10.1177_2333794X19865440-table1)

  Study                                                    No. of Patients   No. of Females/Males   Age Range               Country
  -------------------------------------------------------- ----------------- ---------------------- ----------------------- ---------
  Ejeckam and Nwabueze (1984)^[@bibr8-2333794X19865440]^   100               32/68                  \<20 years              Nigeria
  Reddy et al (2002)^[@bibr10-2333794X19865440]^           100               21/79                  1 month to 12 years     India
  Citak et al (2011)^[@bibr6-2333794X19865440]^            282               124/158                6 months to 16 years    Turkey
  De Corti et al (2014)^[@bibr7-2333794X19865440]^         238               91/126                 3 months to 17 years    Italy
  Gwili et al (2015)^[@bibr9-2333794X19865440]^            49                35/85                  1 month to 18 years     Egypt
  Bozlak et al (2016)^[@bibr5-2333794X19865440]^           218               75/143                 13 months to 18 years   Turkey
  Sarsu and Sahin (2016)^[@bibr11-2333794X19865440]^       1700              697/1003               \<18 years              Turkey

Risk of Bias Within Studies {#section15-2333794X19865440}
---------------------------

One study consisted of patients referred to an oncology clinic.^[@bibr6-2333794X19865440]^ In another study, multiple lymph node aspirates were taken from subjects and the etiologies were reported by the number of aspirates (n = 238) not by the number of subjects (n = 217).^[@bibr7-2333794X19865440]^ Another series reported both cervical and peripheral lymphadenopathy; the diagnoses specific to cervical lymphadenopathy were identifiable, but age and gender data specific to these patients were not.^[@bibr10-2333794X19865440]^

Synthesis of Results {#section16-2333794X19865440}
--------------------

[Table 2](#table2-2333794X19865440){ref-type="table"} summarizes the prevalence rates and credible intervals for the major categories of disease associated with pediatric cervical lymphadenopathy. The majority of cases (67.8%; 95% confidence interval \[CI\] = 66.00-69.60) had no identifiable etiology. Epstein-Barr virus was the most prevalent cause of cervical lymphadenopathy (8.86%; 95% CI = 7.81-9.96), followed by malignancy (4.69%; 95% CI = 3.92-5.52) and granulomatous disease (4.06%; 95% CI = 3.34-4.83). Other less common etiologies included cytomegalovirus (4.02%; 95% CI = 3.31-4.79), group A/β hemolytic streptococcus (2.9%; 95% CI = 2.30-3.57), rubella virus (1.71%; 95% CI = 1.26-2.24), toxoplasmosis (1.19%; 95% CI = 0.82-1.63), and pyogenic abscess (1.04%; 95% CI = 0.69-1.46). Etiologies that occurred at a rate of less than 1% included systemic lupus erythematosus, cat scratch disease, Kawasaki's disease, sarcoidosis, staphylococcal pharyngitis, streptococcal tonsillitis, phlegmon, *Mycoplasma pneumoniae*, parvovirus B19 virus, familial Mediterranean fever, AIDS, dermatomyositis, streptococcal pneumonia, Rosai-Dorfman disease, Kikuchi-Fujimoto disease, PFAPA syndrome, and lymphomatoid papillomatosis.

###### 

Summary by Disease Category.

![](10.1177_2333794X19865440-table2)

  Etiology                              No. of Patients   Prevalence Rate (% of Total)   95% Confidence Interval   
  ------------------------------------- ----------------- ------------------------------ ------------------------- -------
  Nonspecific diagnosis                 1822              67.8                           66                        69.6
  Epstein-Barr virus                    238               8.86                           7.81                      9.96
  Malignant                             126               4.69                           3.92                      5.52
  Granulomatous                         109               4.06                           3.34                      4.83
  Cytomegalovirus                       108               4.02                           3.31                      4.79
  Group A/β Hemolytic *Streptococcus*   78                2.9                            2.3                       3.57
  Rubella                               46                1.71                           1.26                      2.23
  Toxoplasmosis                         32                1.19                           0.816                     1.63
  Abscess                               28                1.04                           0.694                     1.46
  Systemic lupus erythematosus          22                0.819                          0.514                     1.19
  Cat scratch disease                   17                0.633                          0.369                     0.966
  Kawasaki disease                      14                0.521                          0.285                     0.826
  Sarcoidosis                           10                0.372                          0.179                     0.635
  Staphylococcal pharyngitis            8                 0.298                          0.129                     0.536
  Streptococcal tonsillitis             7                 0.261                          0.105                     0.486
  Phlegmons                             6                 0.223                          0.082                     0.434
  *Mycoplasma pneumonia*                3                 0.112                          0.023                     0.269
  Parvovirus B19                        2                 0.0744                         0.00902                   0.207
  Familial Mediterranean fever          2                 0.0744                         0.00902                   0.207
  AIDS                                  2                 0.0744                         0.00902                   0.207
  Dermatomyositis                       2                 0.0744                         0.00902                   0.207
  Streptococcal pneumoniae              1                 0.0372                         0.000943                  0.137
  Rosai-Dorfman disease                 1                 0.0372                         0.000943                  0.137
  Kilkuchi-Fugimoto disease             1                 0.0372                         0.000943                  0.137
  PFAPA syndrome                        1                 0.0372                         0.000943                  0.137
  Lymphomatoid papillomatosis           1                 0.0372                         0.000943                  0.137

[Table 3](#table3-2333794X19865440){ref-type="table"} summarizes the prevalence rates and confidence intervals for malignant causes of cervical lymphadenopathy. Non-Hodgkin's lymphoma was the most common (46%; 95% CI = 37.40-54.70) followed by Hodgkin's lymphoma (27%; 95% CI = 14.70-29.00) and Langerhans cell histiocytosis (2.38%; 95% CI = 0.50, 5.66). Acute lymphocytic leukemia, hemophagocytic lymphohistiocytosis, neuroblastoma, and nonspecific leukemia occurred at rates below 1%.

###### 

Malignant Etiologies in 126 Patients With Cervical Lymphadenopathy.

![](10.1177_2333794X19865440-table3)

  Etiology                             No. of Patients   Prevalence Rate (% of Total)   95% Confidence Interval   
  ------------------------------------ ----------------- ------------------------------ ------------------------- ------
  Unspecified malignant                58                46                             37.4                      54.7
  Non-Hodgkin's lymphoma               34                27                             19.6                      35
  Hodgkin's lymphoma                   27                21.4                           14.7                      29
  Langerhans cell histiocytosis        3                 2.38                           0.498                     5.66
  Acute lymphocytic leukemia           1                 0.794                          0.0203                    2.91
  Hemophagocytic lymphohistiocytosis   1                 0.794                          0.0203                    2.91
  Leukemia                             1                 0.794                          0.0203                    2.91
  Neuroblastoma                        1                 0.794                          0.0203                    2.91

The rates and confidence intervals for the granulomatous disease etiologies of cervical lymphadenopathy are shown in [Table 4](#table4-2333794X19865440){ref-type="table"}. Tuberculosis had the highest rate (73.4%; 95% CI = 64.80-81.20), followed by atypical mycobacteria (22.9%; 95% CI = 15.60-31.20) and nonspecific granulomatous disease (3.67%; 95% CI = 1.02-7.90).

###### 

Granulomatous Disease Etiologies in 109 Patients With Cervical Lymphadenopathy.

![](10.1177_2333794X19865440-table4)

  Etiology                            No. of Patients   Prevalence Rate (% of Total)   95% Confidence Interval   
  ----------------------------------- ----------------- ------------------------------ ------------------------- ------
  Tuberculosis                        80                73.4                           64.8                      81.2
  Atypical mycobacteria               25                22.9                           15.6                      31.2
  Nonspecific granulomatous disease   4                 3.67                           1.02                      7.9

[Table 5](#table5-2333794X19865440){ref-type="table"} summarizes the prevalence rates and confidence intervals for the nonspecific disease etiologies of pediatric cervical lymphadenopathy. Nomenclature across studies for benign etiologies varied considerably. The different terms included nonspecific infectious, unknown, acute reactive lymphadenitis, no defined cause, reactive hyperplasia, nonspecific bacterial lymphadenitis, subchronic reactive lymphadenitis, chronic lymphadenitis, nonspecific noninfectious lymphadenitis, and normal.

###### 

Nonspecific Disease Etiologies in 1822 Patients With Cervical Lymphadenopathy.

![](10.1177_2333794X19865440-table5)

  Etiology                                   No. of Patients   Prevalence Rate (% of Total)   95% Confidence Interval   
  ------------------------------------------ ----------------- ------------------------------ ------------------------- -------
  Nonspecific infectious                     1212              66.5                           64.3                      68.7
  Unknown origin                             219               12                             10.6                      13.6
  Acute reactive lymphadenitis               154               8.45                           7.22                      9.77
  No defined cause                           128               7.03                           5.9                       8.24
  Reactive hyperplasia                       29                1.59                           1.07                      2.21
  Nonspecific bacterial lymphadenitis        25                1.37                           0.89                      1.95
  Subchronic reactive lymphadenitis          20                1.1                            0.672                     1.62
  Lymphadenitis                              14                0.768                          0.421                     1.22
  Chronic lymphadenitis                      12                0.659                          0.341                     1.08
  Nonspecific non-infectious lymphadenitis   7                 0.384                          0.155                     0.716
  Normal                                     2                 0.11                           0.0133                    0.306

Discussion {#section17-2333794X19865440}
==========

Pediatric cervical lymphadenopathy is a common problem with a broad differential diagnosis. Synthesized data obtained from 7 studies representing 5 countries and including 2687 patients demonstrates that two thirds of cases have no identifiable etiology. Of the patients who received a definitive diagnosis, Epstein-Barr virus, malignancy, and granulomatous disease accounted for 8.86%, 4.69%, and 4.06% of cases, respectively. Non-Hodgkin's lymphoma was the most common malignant etiology (46.0% of malignancies), while tuberculosis was the most common granulomatous disease (73.4% of cases of granulomatous origin).

While every article selected for this study did provide an age rage of their subjects, age range of each specific etiology was not always indicated. In the articles with specific malignant etiology identified, subjects were under the age of 18 years, and the youngest subject was between 1 month and 13 months.^[@bibr5-2333794X19865440],[@bibr9-2333794X19865440],[@bibr10-2333794X19865440]^ Also common to all these articles was the presenting symptom of cervical lymphadenopathy. Then depending on other presenting symptoms and examinations, there was further workup of laboratory tests, diagnostic imaging such as ultrasound, fine-needle aspiration, and/or biopsy, which established the malignant etiology.

Common signs found in history included cough, fever, changes in weight, or sore throat.^[@bibr10-2333794X19865440]^ In Citak et al,^[@bibr6-2333794X19865440]^ 3 of the patients with Hodgkin's or non-Hodgkin's lymphoma had weight loss and night sweats; common to all of the patients with lymphoma was the physical examination finding of rubbery and fixed lymph nodes. Other physical examination findings common to lymph nodes of malignant etiology were bilateral, multiple, non-tender nodes that did not present with any skin changes.^[@bibr9-2333794X19865440]^ These findings in the history and physical led to further workup, and some of these predicative factors for malignancy included enlargement of lymph node in follow-up, elevated serum C-reactive protein, lactate dehydrogenase, and uric acid, and leucopenia.^[@bibr5-2333794X19865440]^ Ultrasound findings showed no hilum and undetectable cortical and medullary contours.^[@bibr5-2333794X19865440],[@bibr11-2333794X19865440]^

Regarding the specific etiologies of malignancy found across the articles, unspecified was the most common followed by non-Hodgkin's lymphoma at 27% and Hodgkin's lymphoma at 21%. This is not to say necessarily that non-Hodgkin's is the more common malignant etiology when presenting with cervical lymphadenopathy. Had the other articles specified beyond malignant versus nonmalignant, another malignant etiology may have been made more prevalent. Common to all the articles is a careful history paired with the above physical examination findings and laboratory/diagnostics that then led to a procedure confirming the malignant etiology. These findings help practitioners differentiate between benign and malignant etiology of cervical lymphadenopathy, as the vast majority of the time the etiology will be nonmalignant in nature. Reassuring to both the clinical provider and the pediatric patient and their family is that in the vast majority of cases, the etiology of cervical lymphadenopathy is benign and nonspecific, rather than malignant.

Risk of Bias {#section18-2333794X19865440}
------------

The largest study in this review contributed 63.3% of the total number of subjects.^[@bibr11-2333794X19865440]^ This article was included after analysis of its data showed consistency with the smaller studies. There were many variances in nomenclature to define nonspecific, benign disease. The breakdown of these terms can be seen in [Table 5](#table5-2333794X19865440){ref-type="table"}. The large number of tuberculosis cases reflects the countries of origin included in this study; no large studies from the United States were included in this study.

Limitations {#section19-2333794X19865440}
===========

The main limitations of this study are variations in terminology and diagnostic evaluation across studies illustrated in [Table 5](#table5-2333794X19865440){ref-type="table"}. However, all articles included were required to demonstrate a thorough diagnostic evaluation.

Another limitation of this study was the need to extrapolate data specific to the cervical lymph node region from articles in which etiology and workup of peripheral sites of lymphadenopathy were included. In some articles it was possible to extract the diagnoses pertinent to cervical lymphadenopathy from the included tables. In others, it was not possible to differentiate between the cases of cervical and peripheral lymphadenopathy. In the last instance, only articles in which more than 90% of cases were identified as cervical lymphadenopathy were included.

Finally, given that many of the leading specific etiologies identified in this study are of infectious origin, the locations where the included studies were performed may have influenced the prevalence of certain infectious diseases, primarily tuberculosis. Of the 7 studies included in this meta-analysis, 2 were in tuberculosis endemic regions (Nigeria and India), while the remaining 5 studies took place in regions not endemic for tuberculosis. However, while the tuberculosis rates differed based on study location, the rates of other infections etiologies remained consistent among studies.

Conclusions {#section20-2333794X19865440}
===========

Cervical lymphadenopathy in the pediatric population is a common presenting complaint with myriad possible etiologies. The 3 most common etiologies identified include nonspecific diagnosis, Epstein-Barr virus, and malignancy. As with any systematic review, limitations and potential sources of bias exist. By combining these data with the patient's clinical picture, the treating physician can estimate the probability of a specific diagnosis and more accurately evaluate the need for further diagnostic evaluation.
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